Microbiome Modulation in Cancer Prevention, Personalized Nutrition, and Precision Medicine

Authors: Arora, Monica; Gaurav, Anand; Chaudhary, Amit; Laskar, Tanjima Tarique

Source journal: Advances in experimental medicine and biology (2026-01-01)

DOI: 10.1007/978-981-92-0010-8_4

Abstract

Human microbiome which is a dynamic ecosystem of trillions of microorganisms is important in health and disease, especially in the establishment of cancer in ways such as through inflammation, generation of genotoxins, and immune modulation. This report aims to discuss the concept of microbiome modulation as a preventive and curative approach to cancer along with personalized nutrition and precision medicine. Dysbiosis is also associated with several types of cancers, such as colorectal, breast, and pancreatic whereby pathobionts, such as Fusobacterium nucleatum contribute to tumorigenesis, and beneficial taxa induce protective metabolites such as short-chain fatty acids. Eubiosis is restored through modulation methods such as probiotics, prebiotics, synbiotics, fecal microbiota transplantation, selective antibiotics, and dietary interventions and increase the efficacy of immunotherapy and decrease immunotherapy resistance. Anticancer properties of natural products, including curcumin, resveratrol, and berberine, can be summed up by their capacity to moderate microbiota in terms of achieving anti-inflammatory phenotypes. Gut microbes metabolically modify the food substances to produce bioactive metabolite, which affects the host immunity and epigenetics. Precision nutrition is a system that directs individuals to make diets based on multiomics data, microbiomics included, thereby predicting reactions and avoiding chronic diseases. Genome-scale reconstructions of metabolic models and machine learning computational models mimic these interactions to make personalized predictions. The problems are variability of microbiomes, standardization of data, ethical issues, and causality. In sum, this synthesis provides evidence that the microbiome can help make oncology a treatment centered on reaction to health issues but prevention based on individual needs and subjected to artificial intelligence personalization to allow administering the highest quality health to all the patients.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.